BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 30, 2007
View Archived Issues
Kissei enters development agreement with Nuon Therapeutics for Rizaben
Read More
First milestone investment planned by Amorfix-Biogen Idec partnership
Read More
Oswaldo Cruz Foundation and Genzyme form research collaboration
Read More
Inovio, NCI and IAVI collaborate to evaluate DNA vaccine delivery technology
Read More
Fosalvudine tidoxil monotherapy is safe and effective in treatment-naive HIV-infected patients
Read More
Maraviroc+optimized antiretroviral background therapy safe and effective:MOTIVATE 1 and 2 trials
Read More
Advanced Magnetics changes to AMAG Pharmaceuticals
Read More
ChemoCentryx earns milestone payment from GlaxoSmithKline
Read More
Favorable profile emerges for second-generation HIV-1 maturation inhibitor from Panacos
Read More
Update on Biopure's phase II study of Hemopure
Read More
CHMP grants positive opinion of expanded label of Cubicin
Read More
GMI-1070: GlycoMimetics' lead pan-selectin antagonist drug candidate for sickle cell crisis
Read More
First characterization of a selective nonpeptide formyl peptide receptor-like 1 antagonist
Read More
Siemens to acquire Dade Behring
Read More
ZARS begins phase III trial of ThermoProfen for osteoarthritis
Read More
CytoDyn reports results of DNA vaccine effectiveness comparative study
Read More
Tranzyme begins phase IIb trial of TZP-101 for management of POI
Read More
Kuvan receives priority review status from FDA
Read More
Novel agents for the treatment of endocrine disorders
Read More
Gruenenthal presents analgesic agents targeting monoamine uptake and mu receptors
Read More
New antiinfectives disclosed in patent literature
Read More
Merck to acquire NovaCardia to boost clinical pipeline of cardiovascular drug candidates
Read More
Athersys begins phase I trial for ATHX-105 for treatment of obesity
Read More
Patient treatment begins in phase I/II trial of MDV-3100 in hormone-refractory prostate cancer
Read More
Vyvanse now available in the U.S, for ADHD
Read More
EMEA grants orphan drug status to Active Biotech's cancer treatment Anyara
Read More
OctoPlus obtains full rights to PolyActive drug delivery technology from IsoTis
Read More
Eszopiclone filed for approval in EU and licensed to Eisai in Japan
Read More